Indonesia

GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together.

We aim to positively impact the health of 2.5 billion people over the next 10 years. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance.

We prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease. At the heart of this is our R&D focus on the science of the immune system, human genetics and advanced technologies, and our world-leading capabilities in vaccines and medicines development. We will focus on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.

We have been here in Indonesia for more than 50 years and has manufacturing facility in Pulogadung. We are a company where outstanding people can thrive. Today, GSK Indonesia has employed highly skilled Indonesian talents and are committed to continuously optimize our employment opportunities in Indonesia.

We have a long history of supporting our communities in times of need and have had taken deliberate steps through concrete actions to partner with healthcare associations and governments.

We are committed to continue leverage access of innovative medicines and vaccines to positively impact millions of Indonesia populations and together building a better healthcare ecosystem in Indonesia

Contact details

PT Glaxo Wellcome Indonesia (GSK)
RDTX SQUARE 19th Floor
Jl. Prof. Dr. Satrio, No. 164, Karet Semanggi
Setiabudi, DKI Jakarta, Indonesia
ZIP code: 12930

Telephone: +62 21 2553 2350
Email: cga.indonesia@gsk.com


Email: yqq68540@gsk.com

Our Privacy Notice outlines how GSK handles the processing of personal information when dealing with your enquiry, complaint or adverse event report.

Back to top

Health professionals in Indonesia can obtain information about products and areas of therapy related to GSK by visiting GSKPro

Back to top